Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eliminating Use of Non Depolarizing Neuromuscular Blocking Agents to Reduce Postoperative Pulmonary Complications
NCT03962725Phase 4Terminated
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Aug 2019
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in postoperative pulmonary complications (PPC) (2 arms), sponsored by Beth Israel Deaconess Medical Center. Primary endpoint: Number of Participants Who Either Had Postoperative Pulmonary Complications or Died in Hospital Within 28 Days of Index Procedure. Started Aug 2019; status: terminated.
02
Conditions
postoperative pulmonary complications (PPC)
Beyond the preview
Go deeper on NCT03962725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03962725.